Clinical Trial Update: Pilot Randomized Controlled Study of the Impact of MedRhythms' MR-010 in Acute Stroke [NA]

View source ↗

Summary

A pilot randomized controlled trial assessing MR-010 from MedRhythms in patients with acute stroke was terminated, and the study results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• MR-010

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Stroke, Acute | NA | Status: TERMINATED | Results posted: 2025-01-08